Black Rock Inc. Burning Rock Biotech LTD Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.13 $948 - $1,489	-1,318 Reduced 95.3%	65 $0
Q3 2023 Nov 13, 2023	SELL	$0.91 - $2.29 $36,885 - $92,822	-40,534 Reduced 96.7%	1,383 $1,000
Q1 2023 May 12, 2023	SELL	$2.16 - $3.47 $21,924 - $35,220	-10,150 Reduced 19.49%	41,917 $117,000
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.95 $2.61 Million - $4.44 Million	-1,505,993 Reduced 96.66%	52,067 $117,000
Q3 2022 Nov 14, 2022	SELL	$2.39 - $3.96 $170,796 - $282,993	-71,463 Reduced 4.39%	1,558,060 $3.72 Million
Q2 2022 Aug 12, 2022	BUY	$1.75 - $10.44 $337,354 - $2.01 Million	192,774 Added 13.42%	1,629,523 $4.74 Million
Q1 2022 May 12, 2022	BUY	$6.7 - $10.23 $941,571 - $1.44 Million	140,533 Added 10.84%	1,436,749 $13.3 Million
Q4 2021 Feb 10, 2022	SELL	$9.43 - $17.14 $5.12 Million - $9.31 Million	-543,012 Reduced 29.52%	1,296,216 $12.4 Million
Q3 2021 Nov 09, 2021	BUY	$17.37 - $27.92 $1.81 Million - $2.9 Million	103,921 Added 5.99%	1,839,228 $32.9 Million
Q2 2021 Aug 11, 2021	BUY	$26.14 - $37.45 $45.4 Million - $65 Million	1,735,307 New	1,735,307 $51.1 Million

22.1K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $357M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.